Free Republic

Graphene Oxide is a fairly new substance not yet well understood. But what we do know is that studies have proven it can be toxic to cells and tissues in the body. And further studies have shown Graphene Oxide to have toxic effects on blood cells, inducing oxidative stress and inflammation. This is why it’s concerning to find Graphene Oxide (GO) has been in and out of the news for the past two years in relation to the COVID-19 vaccines developed by Pfizer-BioNTech and Moderna. Several independent studies conducted by doctors and scientists have confirmed that Graphene Oxide is in...

ohnson & Johnson's (NYSE:JNJ) chief litigation lawyer said that the company is weighing the possibility of another bankruptcy filing in its attempt to deal with tens of thousands of lawsuits related to its talcum powder products. If the healthcare giant goes ahead with the filing, it would be the third attempt to use bankruptcy as a way to handle talc litigation after it has been beaten back twice.

(LifeSiteNews) — The U.S. Food and Drug Administration (FDA) has revoked the emergency use authorization (EUA) of the Johnson & Johnson COVID vaccine. The revocation happened officially due to the manufacturer’s own request, according to the FDA. The Johnson & Johnson (J&J) COVID inoculation is produced by its subsidiary Janssen Biotech and was authorized for emergency use on February 27, 2021.“On May 22, 2023, Janssen Biotech, Inc. requested the voluntary withdrawal of the emergency use authorization (EUA) of the Janssen COVID-19 Vaccine,” the FDA website states. “Janssen Biotech, Inc. informed the FDA that the last lots of the vaccine purchased...

The Food and Drug Administration (FDA) announced on May 5 that it will restrict the use of the Johnson & Johnson COVID-19 vaccine to adults who can’t receive mRNA vaccines because of the risk of potentially life-threatening side effects.The agency said the COVID-19 vaccine can now only be administered to people aged 18 years of age and older who can’t receive either the Moderna or Pfizer vaccines, both of which are two-dose vaccines and use mRNA technology. J&J’s single-shot vaccine uses adenovirus technology.People 18 and older who want to receive the J&J vaccine “because they would otherwise not receive a...

The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. U.S. authorities for months have recommended that Americans starting their COVID-19 vaccinations use the Pfizer or Moderna shots instead. FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two weeks of vaccination. J&J's vaccine was initially considered an important tool in fighting the pandemic because it required only one shot. But the single-dose option proved less effective...

Drugmaker Johnson & Johnson has halted production of its single-dose COVID-19 vaccine, according to a New York Times report. The pharmaceutical company last year quietly shut down production at a plant in Leiden, Netherlands, which was the only facility where usable doses of the vaccine were manufactured, catching some of its customers off guard, the report states. Johnson & Johnson has instead been using the plant to work on an experimental and potentially more profitable drug that could protect against an unrelated respiratory virus, according to the report.

A major pharmaceutical company this week fired many employees who refused to get the COVID-19 vaccine. Syneos Health is a global pharmaceutical outsourcing company with some 28,000 employees in more than 110 countries. It contracts with bigger pharmaceutical companies including COVID-19 vaccine maker Johnson & Johnson/Janssen.While J & J employs pharmaceutical representatives, it also contracts with Syneos Health to provide additional pharmaceutical representatives. Each Syneos representative is paired with one from J&J and they work together, selling drugs to doctors and other health care providers.“It’s the same exact job, same exact customers, same exact expense reporting. Everything is the same,...

CHARLOTTESVILLE, Va. (WVIR) - Doctor Patrick Jackson with the University of Virginia has advice for people looking to get vaccinated. Dr. Jackson says COVID-19 vaccines have a very low Myocarditis or heart inflammation risk, however the risk is highest in young men. He says says the Johnson & Johnson vaccine does not have any association with this side effect and could be the best choice for some. “Now that we have more data about these vaccines people can talk to their doctors about which vaccine might be the ideal one for them, or even now that we have some flexibility,...

The Centers for Disease Control and Prevention on Thursday recommended Pfizer’s and Moderna’s vaccines over Johnson & Johnson’s shot for adults, after finding dozens of people developed a rare blood clot condition following vaccination with J&J shots. All of those patients were hospitalized, and nine died. The CDC has confirmed 54 cases of people developing blood clots and showing low blood platelet levels — a new condition called thrombosis with thrombocytopenia syndrome, or TTS, which mostly affects younger women. Of those cases, 36 required treatment in intensive care. In a statement Thursday evening, the CDC said the U.S. has an...

The Johnson & Johnson vaccine, perhaps more than any other COVID shot, knows what it is to be bullied... Tweets, memes, and listicles dragged it... The underdog dose, the “second class” shot, the nation’s vaccine-a non grata, seemed as good as dead... It’s still early, but [immunologist] Collier thinks the dynamics might look a bit different for people who got a single dose of J&J. Her recent work shows that their antibody levels start significantly lower than mRNA recipients’, but that eight months out from vaccination, the numbers have stayed stable, and have, perhaps, even gone up.

Johnson & Johnson's COVID-19 vaccine increases a person's risk of developing rare blood clots, a new study suggests. Researchers from the Mayo Clinic in Rochester, Minnesota, compared data from the general population before the pandemic to data gathered from reported vaccine side-effects suffered by Americans. They found that a person who received the vaccine was 3.5 times as likely to develop brain blood clots as an average person before the pandemic. Blood clotting, and specifically cerebral venous sinus thrombosis (CVST) is a well known side-effect of the J&J vaccine, and the discovery of this risk was the reason usage of...

SNIPThey found that a person who received the vaccine was 3.5 times as likely to develop brain blood clots as an average person before the pandemic.SNIP

Vaccination: As of October 22, 2021, 96.1% of Seniors (65+) have received at least one dose of vaccine and 84.6% are fully vaccinated. More than three-quarters (79.3%) of Adults (18+ years old) have received at least one dose of vaccine and 68.8% are fully vaccinated. 57.2% of the total US population has been fully vaccinated (190 Million), a +0.5 Percentage point increase from last week. Reported Cases: The current 7-day moving average of daily new cases (73,079) decreased 15.1% compared with the previous 7-day moving average (86,046). New Hospital Admissions: The current 7-day daily average for October 13–October 19, 2021,...

Nordic countries have already issued directives to withhold specific vax from younger patients. The U.S. Food and Drug Administration this week announced that it would delay the authorization of Moderna’s COVID-19 vaccine for adolescents while it studies reports of an adverse heart reaction to the drug in younger patients. Sources told the Wall Street Journal that “the FDA has been taking another look at the risk of the condition, known as myocarditis, among younger men who took Moderna’s vaccine,” especially compared to those who received other brands of the vaccine.” The investigation comes shortly after the Nordic countries announced their...

As of October 14, 2021, 95.4% of people ages 65 years or older have received at least one dose of vaccine and 84.2% are fully vaccinated. More than three-quarters (78.6%) of people ages 18 years or older have received at least one dose of vaccine and 68.1% are fully vaccinated. Reported Cases: The current 7-day moving average of daily new cases (84,555) decreased 12.5% compared with the previous 7-day moving average (96,666). New Hospital Admissions: The current 7-day daily average for October 6–October 12, 2021, was 6,659. This is an 8.8% decrease from the prior 7-day average (7,303) from September...

The United States reached a grim milestone this week, surpassing 700,000 total deaths from COVID-19. This week also, the total of vaccine doses administered in the USA surpassed 400 million. Reported Cases: The current 7-day moving average of daily new cases (95,448) decreased 11.6% compared with the previous 7-day moving average (107,953). New Hospital Admissions: The current 7-day daily average for September 29–October 5, 2021, was 7,440. This is a 13.2% decrease from the prior 7-day average (8,378). Deaths: The current 7-day moving average of new deaths (1,431) has decreased 8.4% compared with the previous 7-day moving average (1,563). Vaccination:...

Reported Cases: The current 7-day moving average of daily new cases (106,395 per day) decreased 13.3% compared with the previous 7-day moving average (122,659). The national proportion of cases attributed to the Delta variant is estimated to be greater than 99%. Nowcast estimates indicate that Delta will continue to be the predominant variant circulating in all 10 U.S. Department of Health and Human Services (HHS) regions. The percentage of COVID-19 NAATs (nucleic acid amplification tests) that are positive (percent positivity) (6.6%) has decreased from the previous week (7.4%) - a relative drop of 11.1%. Vaccination: The 7-day average number of...

Booster doses are most recommended for adults age 65 and up, who generally don't have the same kind of strong, lasting immune response to vaccines as younger people. But there's no federal guidance about whether people who've gotten Moderna's or Johnson & Johnson's COVID-19 vaccines might need a boost. Emerging evidence suggests that people on #TeamModerna may not need a booster as much as others. Last week, the Centers for Disease Control and Prevention released data sets from hospitals around the country. That data is starting to indicate that people who got Moderna's vaccine are less likely to be hospitalized...

Johnson & Johnson: Children Don’t Need the [bleeping] COVID Vaccine Because There Are ‘Unknown Repercussions Down the Road’ … Want to ‘Punish’ Unvaccinated Adults and Turn Them Into ‘Second-Grade Citizens’ for Not Complying with MandatesBrandon Schadt, Johnson & Johnson Regional Business Lead: “It’s a kid, you just don’t do that, you know? Not something that’s so unknown in terms of repercussions down the road, you know?” Schadt: "Kids shouldn't get a [bleeping] [COVID] vaccine." Schadt: “It’s a kid, it’s a [bleeping] kid, you know? They shouldn’t have to get a [bleeping] [COVID] vaccine, you know?” Schadt: “J&J is like stepping...

(President Trump's Operation Warp Speed Update) (New Cases Plunging! Down a third in two weeks. - Hospitalizations accelerating downward toward a plunge - Daily Deaths still high (2,177), but appear to be levelling off - Vaccinations strong (745K/day)) Administered: 389,372,689 (14,925,576 J&J) People Vaccinated, At Least One Dose: 213,177,462 Fully Vaccinated: 183,353,326 Boosters: 2.53 Million